Jenkins AJ, Krishnamurthy B, Best JD, Cameron FJ, Colman PG, Farish S, Hamblin PS, O'Connell MA, Rodda C, Rowley K, Teede H, O'Neal DN. Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial. Diabetes Care 2010;33:1242–1248
In the print version of the article listed above, under the “Conclusions” heading in the 2nd sentence of the 5th paragraph, the sentence incorrectly reads: “Some RT-CGM studies followed participants two to three times weekly (7,9) in person or by telephone (I. Hirsch, MD, University of Washington, personal communication), although recent evidence suggests a benefit for RT-CGM in conventional clinical settings (16).” The corrected sentence reads: “Some RT-CGM studies followed participants at intervals of 2–3 weeks (7,9) in person or by telephone (I. Hirsch, MD, University of Washington, personal communication), although recent evidence suggests a benefit for RT-CGM in conventional clinical settings (16).” The online version reflects these changes.